DermConsult

Host: Raj Chovatiya, MD, PhD Guest: Steven R. Feldman, MD, PhD The biologics we know are revolutionary treatments for our patients with psoriasis and now other inflammatory skin diseases. So how do biosimilars play a part in the evolving treatment of psoriasis? Learn more with Dr. Raj Chovatiya as he dives further into biosimilars with Dr. Steve Feldman, Professor of Dermatology, Pathology, Social...

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurativa (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical S...

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD For patients with hidradenitis suppurativa (HS), the exact cause of the condition is still being researched. So what therapies are currently available to treat this painful condition? To discuss what you need to know, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Profe...

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD The future looks promising for alopecia areata patients as two JAK inhibitors have been tested in clinical trials while other treatment studies are ongoing. So what should clinicians know about these therapies? Learn more as Dr. Raj Chovatiya speaks to Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Bo...

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD Initially approved for the treatment of rheumatoid arthritis, baricitinib is now the first FDA-approved treatment for patients with alopecia areata. So what can patients look forward to with this new therapy? Dive in with Dr. Raj Chovatiya as he’s joined by Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Doub...

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Justin Cheeley, MD Proper access to medication can present challenges for the doctor and patient but is necessary to achieve optimal patient outcomes. So how can they work together to eliminate this burden? To discuss this further, Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of Gener...

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Justin Cheeley, MD Patients with IBD, arthritis, or other disorders of the immune system may be at a higher risk for developing pyoderma gangrenosum (PG). So how can clinicians better manage their patients with PG? Explore this rare condition as Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Depart...

Host: Matthew S. Keller MD Host: Monica Schwartzman, MD, MS Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians help patients find the right medication? To discuss this topic together, Dr. Matthew Keller is joined by fellow ReachMD host, Dr. Monica Schwartzman, who is also a Rheumatologist.

Host: Michael Greenberg, MD Guest: Jonathan S. Weiss, MD Physician assistants (PAs) are licensed to practice medicine to provide many of the same services as a physician. And they may even train in dermatology. But what do we need to take into consideration when bringing a PA into a dermatology practice? Joining Dr. Michael Greenberg to discuss the ethics of this all-too-common situation is Dr. Jo...

Host: Matthew S. Keller MD Guest: Natasha Mesinkovska, MD, PhD Alopecia areata affects more than 300,000 people in the United States each year, causing hair loss to the scalp, eyebrows, and eyelashes. But recent studies have shown that the Janus kinase inhibitor drug baricitinib can help significantly regrow hair for patients. To find out more about what this first-ever FDA approval of a systemic...

Host: Michael Greenberg, MD Guest: Lynn McKinley-Grant, MD, FAAD Psoriatic disease looks and feels different for people of color, and these differences may affect their diagnosis, treatment, and—by extension—quality of life. In fact, more than 50 percent of people with psoriatic arthritis experience a 2-year delay in diagnosis and a lower quality of life compared to white patients. So how can we h...

Host: Michael Greenberg, MD Guest: Esther Freeman, MD, PhD Guest: Steven Chen, MD, MPH, MHPEd With the recent rise of monkeypox cases around the world, dermatologists will be some of the first to evaluate and diagnose patients with the disease. So to help those on the frontlines, Dr. Esther Freeman, Director of Global Health Dermatology at Massachusetts General Hospital and Dr. Steven Chen, Assist...

Host: Michael Greenberg, MD Guest: Brook Brouha, MD, PhD How might genomics help us provide better care for our patients? Joining Dr. Michael Greenberg to share how he’s utilizing genomics in practice is Dr. Brook Brouha, a dermatologist and dermatopathologist at West Dermatology in San Diego, California.

Host: Matthew S. Keller MD Guest: Michael Greenberg, MD Are you looking to increase business at your dermatology practice? One simple solution is practicing goodness—in other words, being good and kind to your patients and their families. Joining Dr. Matthew Keller to explain why goodness is the best practice builder is fellow ReachMD Host Dr. Michael Greenberg.

Host: Michael Greenberg, MD Guest: Dustin Portela, DO The prevalence of social media has grown significantly over the past few decades, and within the field of medicine, we’ve seen a rise in dermatologists using these platforms to grow their professional network, improve patient care, and provide essential education. But what ethical challenges arise from a widespread social media presence, and ho...

Host: Matthew S. Keller MD Guest: Shawn Kwatra, MD As the most common type of eczema, atopic dermatitis is a chronic, inflammatory skin disorder that affects millions of people worldwide. And although it’s a complex disease with no cure, the FDA recently approved two oral JAK-1 inhibitors for patients with mild-to-severe-symptoms. So what do we need to know about these new treatment options? Joini...

Host: Michael Greenberg, MD Guest: Arash Mostaghimi, MD, MPA, MPH Acne vulgaris is a common dermatologic condition with a variety of treatment options available. But due to its multifactorial pathogenesis and the limitations of current therapies, evolving treatments and management guidelines are needed. Fortunately, several therapies have emerged in recent years, so to learn more about what’s new...

Host: Matthew S. Keller MD Guest: Linda Stein Gold, MD For many years, acne scarring was considered to be a result of severe acne, but recent research shows that scarring can affect any patient regardless of the severity. Additionally, acne scarring can significantly reduce a patient's quality of life, which is why it's important that treatment is started early to achieve better outcomes. So to he...

Host: Michael Greenberg, MD Host: Matthew S. Keller MD How do you respond when your patient’s frustrations—and even perhaps your own—creep into a visit? And how can you incorporate professional intimacy into your practice? Find out in part 2 of Dr. Matthew Keller and Dr. Michael Greenberg’s discussion on how we can improve our bedside manner.

Host: Michael Greenberg, MD Host: Matthew S. Keller MD As clinicians, we often need to address our patients’ emotional health just as much as their physical health, and bedside manner plays a big part in that. So to help ensure our patients are getting the most out of their visits, Drs. Matthew Keller and Michael Greenberg come together in this two-part discussion to share their tips for improving...

Host: Michael Greenberg, MD Guest: Howard K. Steinman, MD We always want patients to leave our office feeling happy, healthy, and pleased with their care, but unfortunately, that isn't always the case. The good news, however, is that the acronym BLAST can help guide our conversations with patients who are less than satisfied with their care. Joining Dr. Michael Greenberg to break down this five-st...

Host: Michael Greenberg, MD Guest: Robert T. Brodell, MD As children, stories and fables capture our imaginations and even teach us some important life lessons, and our love of stories isn't necessarily something we grow out of. After all, as adults, we're constantly hearing news stories and catching the latest movies, podcasts, and shows. So might there be a role for storytelling in our visits wi...

Host: Matthew S. Keller MD Guest: Omer Ibrahim, MD In this episode, you’ll hear from board-certified dermatologist Dr. Omer Ibrahim about the rising prevalence of bed bug infestations, diagnostic and treatment strategies, and how we can help patients manage and prevent bed bug infestations.

Host: Michael Greenberg, MD Guest: Joel Schlessinger, MD Spa dermatology has morphed over the last 20 to 30 years, but not all of those changes benefited our patients. In fact, there are now several ethical and practical concerns when it comes to illegitimate med spas. Joining Dr. Matthew Keller to share those considerations and what we as dermatologists need to know so we can help guide our patie...

Host: Michael Greenberg, MD Guest: Sam Polesie, PhD Can technology play a role in assessing melanoma? Dr. Michael Greenberg discusses the use of artificial intelligence in dermatology with Dr. Sam Polesie, a specialist physician in the Department of Dermatology and Venereology at the Sahlgrenska University Hospital in Gothenburg, Sweden.